tk88 bet

Challenges remain in hepatitis C diagnosis, treatment: workshop

A workshop held in Hanoi on September 24 pointed out that there remain numerous challenges in the diagnosis and treatment of hepatitis C in Vietnam.
Challenges remain in hepatitis C diagnosis, treatment: workshop ảnh 1Director of the National Hospital for Tropical Diseases Nguyen Van Kinh speaks at the workshop in Hanoi on September 24 (Photo: VNA)

Hanoi (VNA) – A workshop held in Hanoi onSeptember 24 pointed out that there remain numerous challenges in the diagnosisand treatment of hepatitis C in Vietnam.

Hepatitis C is one of the leading causes ofcirrhosis and liver cancer in the country, which has recorded high incidencesof hepatitis B and C.

Director of the National Hospital for TropicalDiseases Prof. Dr. Nguyen Van Kinh said there haven’t been any vaccines againsthepatitis C, but this disease can be treated thanks to new drugs that directlyattack the virus.

However, the access to these drugs is stilllimited due to high treatment costs, the drugs not covered by health insurance,and a lack of diagnosis and treatment services.

These are major challenges to the support forand treatment of hepatitis C patients, Kinh noted.

It is estimated that Vietnam has nearly 8million people infected with hepatitis B and 1 million others contracted hepatitisC, ranking third in the world and second in Asia in terms of hepatitisincidence.

Data released by the World Health Organisation (WHO)show that in 2017, among the nearly 1 million people infected with hepatitis C,only more than 80,000 were diagnosed, nearly 35,000 had conditions to receivetreatment, and 4,500 were treated.

Meanwhile, public awareness of hepatitis remainslow. As a result, only when the diseases become serious and develop intocirrhosis or liver cancer do they come to hospitals to have check-ups.

Therefore, people are recommended to haveregular health check-ups, take screening for hepatitis B and C, and avoiddrinking alcohol to prevent hepatitis infection.

To support Vietnam to enhance hepatitisdiagnosis and treatment, the Clinton Health Access Initiative has engaged thecountry in its Quick-Start programme, which has also involved five othernations. 

Under this programme, 2,018 hepatitis C patientshave received treatment, and 98 percent of those with treatment resultsrecorded have recovered./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

💟 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

꧒ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

♊ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|